In the case of 'non-stomach cancer cell lines', addition of GAPDH as the third gene to the two optimally expected genes B2M-RPL29 increases by 0.0218 of the stability value M, with its pair-wise variance V2/3 of 0.032. Here, RPL29 is linked to gastric neoplasm.